Clinical Trial Update: Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary Plaque

View source ↗

Summary

A GE Healthcare-led clinical trial is evaluating the feasibility of a deep learning-based, non-invasive approach to assess vulnerable coronary plaque; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Stable Angina

Snippet

Sponsor: GE Healthcare | Conditions: Chronic Coronary Syndrome, Coronary Artery Disease | Status: NOT_YET_RECRUITING